Zoloft Can Increase Risk of Persistent Pulmonary Hypertension of the Newborn

more+
less-

The Food and Drug Administration (FDA) has warned that the use of Zoloft or other SSRI antidepressants during pregnancy can increase a newborn’s risk of a circulatory condition known as persistent pulmonary hypertension of the newborn (PPHN) .

LOADING PDF: If there are any problems, click here to download the file.

Published In: Consumer Protection Updates, Health Updates, Personal Injury Updates, Products Liability Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Hissey Kientz LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »